ABIVAX Société Financials
| AAVXF Stock | USD 11.05 0.00 0.00% |
ABIVAX |
Understanding current and past ABIVAX Société Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ABIVAX Société's financial statements are interrelated, with each one affecting the others. For example, an increase in ABIVAX Société's assets may result in an increase in income on the income statement.
ABIVAX Société Stock Summary
ABIVAX Société competes with Northwest Biotherapeutics, and Geron. ABIVAX Socit Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. The company was incorporated in 2013 and is headquartered in Paris, France. Abivax Sa is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 5, rue de |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.abivax.com |
| Phone | 33 1 53 83 08 41 |
| Currency | USD - US Dollar |
ABIVAX Société Key Financial Ratios
There are many critical financial ratios that ABIVAX Société's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that ABIVAX Socit Anonyme reports annually and quarterly.| Return On Equity | -12.86 | |||
| Return On Asset | -0.44 | |||
| Number Of Employees | 24 | |||
| Beta | 1.26 | |||
| Z Score | 1.8 |
ABIVAX Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ABIVAX Société's current stock value. Our valuation model uses many indicators to compare ABIVAX Société value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ABIVAX Société competition to find correlations between indicators driving ABIVAX Société's intrinsic value. More Info.ABIVAX Socit Anonyme is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ABIVAX Société's earnings, one of the primary drivers of an investment's value.ABIVAX Socit Anonyme Systematic Risk
ABIVAX Société's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ABIVAX Société volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on ABIVAX Socit Anonyme correlated with the market. If Beta is less than 0 ABIVAX Société generally moves in the opposite direction as compared to the market. If ABIVAX Société Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ABIVAX Socit Anonyme is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ABIVAX Société is generally in the same direction as the market. If Beta > 1 ABIVAX Société moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for ABIVAX Pink Sheet analysis
When running ABIVAX Société's price analysis, check to measure ABIVAX Société's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABIVAX Société is operating at the current time. Most of ABIVAX Société's value examination focuses on studying past and present price action to predict the probability of ABIVAX Société's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABIVAX Société's price. Additionally, you may evaluate how the addition of ABIVAX Société to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |